Generation and characterization of coupling factor 6-overexpressing transgenic mice

Hirosaki Medical Journal

Volumn 60, Issue 1-4, 2009, Pages 18-26

  Ashitate, Toshihiro ^a   Osanai, Tomohiro ^a   Tanaka, Makoto ^a   Magota, Koji ^b   Echizen, Takashi ^a   Tomita, Hirofumi ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Congestive heart failure; Coupling factor 6; Energy metabolism; High salt loading; Transgenic mice

Indexed keywords

EID: 64849113521     PISSN: 04391721     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Boyer PD. The binding change mechanism for ATP synthase: Some probabilities and possibilities. Biochim Biophys Acta 1993;1140:215-250.
2. 1-ATPase from bovine mitochondria. J Mol Biol 1985;184:677-701.
3. Kagawa Y, Racker E. Partial resolution of the enzyme catalyzing oxidative phosphorylation: Correlation of morphology and function in submitochondrial particles. J Biol Chem 1966:241:2475-2482.
4. Walker JE, Runswick MJ, Poulter L. ATP synthase from bovine mitochondria: Characterization and sequence analysis of two membrane associated subunits and of the corresponding c-DNAs. J Mol Biol 1987;197:89-100.
5. 1-ATPase and its absence. J Mol Biol 1994:242:408-421.
6. Osanai T, Kamada T, Fujiwara N, Katoh T. Takahashi K, Kimura M, Satoh K, et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneous hypertensive rats. J Biol Chem 1998;273:31778-31783.
7. Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, Sirato K, et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest 2001;108:1023-1030.
8. Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, et al. Intracellular signaling for vasoconstrictor coupling factor 6: Novel function of β-subunit of ATP synthase as receptor. Hypertension 2005;46:1140-1146.
9. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350:1953-1959.
10. Osanai T, Okada S, Sirato K, Nakano T, Saitoh M, Magota K, Okumura K. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 2001;104:3132-3136.
11. Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K. Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 2004;62:578-586.
12. 2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 2005;67:134-141.
13. Lemmens K, Fransen P, Sys SU, Brutsaert DL, Keulenaer GWD. Neuregulin-1 induces a negative inotropic effect in cardiac muscle. Role of nitric oxide synthase. Circulation 2004;109:324-326.
14. Fisher C, MacLean M, Morecroft I, Seed A, Johnston F, Hillier C, et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation 2002;106:292-295.
15. Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, Matsunaga T, et al. Circulating coupling factor 6 in human hypertension: Role of reactive oxygen species. J Hypertens 2003;21:2323-2328.
16. Ding WH, Chu SY, Jiang HF, Cai DY, Pang YZ, Tang CS, Qi YF. Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction. Hypertens Res 2004;27:717-722.
17. Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, Yamabe H, et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003;64:2291-2297.
18. Li XL, Xing QC, Gao YY, Dong B, Pang YZ, Jiang HF, Tang CS. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 2007;117:411412.
19. Matsumoto H, Rogi T, Yamashiro K, Kodama S, Tsuruoka N, Hattori A, Takio K. et al. Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 2000:267:46-52.
20. MacDonald MJ: Evidence of the malate aspartate shuttle in pancreatic islet. Arch Biochem Biophys 1982;213:643-649.
21. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997;34:25-33.
22. Carly AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005;1734:112-126.
23. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, et al. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 2000;18:111-120.
24. Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt Am J Physiol Heart Circ Physiol 2000;279:H7-H14.